Cycle-length evidence
Argireline cycle length: what human studies ran
Not approved — research use onlyBLimited human data
Short answer: there is no established Argireline cycle length, and we found no human studies that report one.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Argireline combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Argireline cycle length?
No. We found no human studies that report a treatment duration for Argireline.
What is the longest human study of Argireline?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics Int J Toxicol. 2025
- Acetyl Hexapeptide-8 in Cosmeceuticals - A Review of Skin Permeability and Efficacy Int J Mol Sci. 2025
- Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia Complexion Analysis camera system for objective skin analysis GMS Interdiscip Plast Reconstr Surg DGPW. 2023
- Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet J Clin Aesthet Dermatol. 2023
- Effects of Botulinum Toxin Type A and Argireline on Dermal Collagen Remodeling and Skin Biology in a Flap Model Aesthetic Plast Surg. 2026
- Acetyl Hexapeptide-8 as a Topical Alternative to Botulinum Toxin: A Review of the Literature J Drugs Dermatol. 2025
- Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis JMIR Dermatol. 2024
- Acetyl hexapeptide-3 / Acetyl Hexapeptide-8 (CID 71587772) PubChem. 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026); no entry for acetyl hexapeptide or argireline in any of the three categories FDA. 2026
- International Standard: Prohibited List 2026 World Anti-Doping Agency. 2026
- Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS) Biomol Ther (Seoul). 2014
- The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies Int J Cosmet Sci. 2026